Bacterial Peritonitis
Learn about Bacterial Peritonitis (SBP) diagnosis, including clinical documentation and medical coding for Spontaneous Bacterial Peritonitis. Find information on healthcare best practices for SBP and Bacterial Peritonitis, covering diagnosis, treatment, and management. This resource is designed for healthcare professionals seeking information on accurate and efficient clinical documentation and medical coding related to Bacterial Peritonitis and Spontaneous Bacterial Peritonitis.
Infection of the abdominal fluid (ascites), typically without an obvious source.
Fever, abdominal pain, tenderness, altered mental status, low blood pressure.
Cirrhosis, liver failure, ascites, immunocompromised patients.
ICD-10 Code Families
Complete code families applicable to K65.0
When to use each related code
| Description | When to use |
|---|---|
| Bacterial infection of the abdominal cavity lining. | Use for confirmed bacterial peritonitis, primary or secondary. Consider SBP in ascites patients with infection. |
| Inflammation of the abdominal cavity lining, not caused by bacteria. | Use for peritonitis with non-bacterial causes like fungal, chemical, or tuberculous. Exclude bacterial causes first. |
| Ascites fluid infection in patients with liver disease, often without clear source. | Use specifically for ascites patients with suspected or confirmed spontaneous bacterial peritonitis (SBP). |
Best-practice checklist
- ✓Document ascites fluid analysis results (e.g., WBC, neutrophils, culture)
- ✓Record patient history and physical exam findings related to SBP
- ✓Specify infection source if known (e.g., urinary tract, bloodstream)
- ✓Document antibiotic treatment and patient response to therapy
- ✓Include ICD-10 code K65.2 (Bacterial peritonitis)
Common pitfalls to avoid
Coding bacterial peritonitis without specifying the causative organism when documented can lead to rejected claims and inaccurate severity reflection.
Miscoding spontaneous bacterial peritonitis (SBP) as secondary bacterial peritonitis or vice versa impacts quality reporting and reimbursement.
Failing to code the underlying cirrhosis frequently associated with SBP can lead to inaccurate risk adjustment and resource allocation.
Best-practice tips
- 01Timely paracentesis for SBP diagnosis: ICD-10 K65.2
- 02Document SAAG, PMN count for accurate SBP coding, CDI
- 03Antibiotic initiation within 6 hours of SBP diagnosis improves outcomes
- 04Culture results crucial for targeted therapy, compliance: LOINC 26454-7
- 05Monitor, document patient response to antibiotics for optimal care
Step-by-step checklist
- 1
Ascitic fluid: PMN count >250/mm3?
- 2
Signs/symptoms: Fever, chills, abdominal pain/tenderness?
- 3
Underlying liver disease (cirrhosis, etc.) documented?
- 4
Culture of ascitic fluid performed?
- 5
Consider secondary bacterial peritonitis if no underlying liver disease.
Ready-to-paste narrative
Patient presents with symptoms suggestive of bacterial peritonitis, including diffuse abdominal pain, tenderness to palpation, guarding, rigidity, rebound tenderness, and fever. Ascites is present, confirmed by physical exam and or imaging. Paracentesis was performed, and ascitic fluid analysis revealed a polymorphonuclear leukocyte (PMN) count greater than 250 cells/mm3, consistent with the diagnostic criteria for spontaneous bacterial peritonitis (SBP). Differential diagnosis includes secondary bacterial peritonitis, but given the absence of an intra-abdominal source of infection, such as a perforated viscus, SBP is the most likely diagnosis. Blood cultures were also drawn to assess for systemic infection. The patient's medical history includes cirrhosis, a significant risk factor for SBP. Treatment initiated with intravenous antibiotics, specifically a third-generation cephalosporin such as cefotaxime, to cover common causative organisms like Escherichia coli and Klebsiella pneumoniae. Patient will be monitored for response to therapy, including improvement in abdominal pain, fever, and laboratory markers of infection. Prophylactic antibiotic therapy will be considered for secondary prevention of SBP recurrence. Assessment and management of complications, such as hepatorenal syndrome and hepatic encephalopathy, are ongoing. This diagnosis of bacterial peritonitis will necessitate accurate ICD-10 coding (K65.2) for appropriate medical billing and reimbursement. The patient's clinical status will be closely followed, and adjustments to the treatment plan will be made as needed.
Common questions and answers
What are the most accurate diagnostic criteria for spontaneous bacterial peritonitis (SBP) in patients with ascites, and how do I differentiate it from secondary bacterial peritonitis?+
Diagnosing spontaneous bacterial peritonitis (SBP) accurately requires a combination of clinical findings and paracentesis analysis. The most widely accepted diagnostic criterion is an ascitic fluid absolute neutrophil count (ANC) greater than or equal to 250 cells/mm3. While clinical symptoms like fever, abdominal pain, and altered mental status can be present, they are often nonspecific. Differentiating SBP from secondary bacterial peritonitis (caused by a perforated viscus, for example) is crucial. Secondary peritonitis often presents with a more acute onset, localized abdominal pain, and evidence of an intra-abdominal source on imaging. Ascitic fluid analysis in secondary peritonitis may show a polymicrobial infection, a higher total white cell count, and a lower pH compared to SBP. Consider implementing a standardized paracentesis protocol to ensure proper sample handling and interpretation. Learn more about the role of ascitic fluid protein and glucose levels in the differential diagnosis of ascites.
How do I effectively manage and treat a patient with culture-positive spontaneous bacterial peritonitis (SBP), considering antibiotic resistance patterns and potential complications?+
Effective management of culture-positive spontaneous bacterial peritonitis (SBP) requires prompt initiation of empiric antibiotic therapy, typically with a third-generation cephalosporin like cefotaxime. Given increasing antibiotic resistance, consider local antibiograms and tailoring treatment based on culture and sensitivity results. Intravenous albumin administration has been shown to improve renal function and reduce the risk of hepatorenal syndrome and other complications, particularly in patients with severe SBP. Close monitoring for treatment response, including repeat paracentesis if clinically indicated, is essential. Explore how current guidelines recommend monitoring for and managing potential complications such as hepatic encephalopathy and hepatorenal syndrome in patients with SBP.
What prophylactic measures can be implemented to prevent recurrent spontaneous bacterial peritonitis (SBP) in high-risk cirrhotic patients, and what factors influence the choice of prophylactic strategy?+
Recurrent spontaneous bacterial peritonitis (SBP) is a significant concern in cirrhotic patients. Prophylactic antibiotics, such as norfloxacin or ciprofloxacin, are often recommended for patients with a prior episode of SBP, low ascitic fluid protein levels (less than 1.5 g/dL), or variceal bleeding. The choice of antibiotic prophylaxis should consider individual patient factors, including renal function and potential drug interactions. Non-selective beta-blockers, primarily used for variceal bleeding prophylaxis, may also offer a degree of SBP prevention. Learn more about the evolving role of probiotics and other emerging strategies for preventing SBP in high-risk cirrhotic patients. Explore how risk stratification tools can help personalize preventative strategies and improve patient outcomes.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.